Health Trials

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

ConditionsDiabetesObesity & OverweightCushing SyndromeMetabolic DiseasesEndocrine DiseasesSarcopeniaSarcopenic Obesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain

About this trial

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.

.

Eligibility criteria

Qualifiers

Metabolic or endocrine disease

Disqualifiers

Known myopathy

Systemic steroid use (> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome

Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol

History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor

Trial design

Treatments tested in this trial

  • GLP-1 Receptor Agonists

Treatment groups

No treatment groups listed

Sponsors and collaborators

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Lead sponsor

Source ClinicalTrials.gov